-
December 30, 2020Elpiscience was Named as One of the Cultivated Unicorn Enterprises of Suzhou
Shanghai/Suzhou, China, 30th December 2020. Elpiscience Biopharma Ltd., a clinical stage biotech company focusing on the discovery and development of next-generation cancer immunotherapies, was named ...
-
June 15, 2020Elpiscience Announces IND Submission of ES102
Shanghai, China, 15th July 2020. Elpiscience Biopharma Ltd., a clinical stage biotech company focusing on the discovery and development of next-generation cancer immunotherapies announced today t...
-
May 28, 2020Elpiscience Announces Clinical collaboration with Junshi Biosciences
Shanghai, China, May 28th, 2020. Elpiscience Biopharma Ltd., a clinical stage biotech company focusing on the discovery and development of next-generation cancer immunotherapies announced today t...
-
May 26, 2020Elpiscience to Present at the Jefferies 2020 Healthcare Conference
Shanghai, China, May 26th, 2020. Elpiscience Biopharma Ltd., a clinical stage biotech company focusing on the discovery and development of next-generation cancer immunotherapies, today announced ...
-
January 06, 2020Elpiscience Appoints Dr. Steve Chin as Chief Medical Officer
Shanghai, January 6, 2020. Elpiscience Biopharma, Ltd., a clinical-stage biopharmaceutical company announces the appointment of Steve Chin, M.D. as Chief Medical Officer. Dr. Chin brings to th...
-
December 28, 2019Elpiscience Completes Series B Financing of USD $100 Million
December 28, 2019, Shanghai, China, Elpiscience Biopharma announces the completion of Series B financing of 100 million USD. The round was led by Hyfinity Investments, with participation from Tencent,...